A Phase II Exploratory Study Examining Immunologic and Virologic Indices in Two Age-Differentiated Cohorts of HIV-Infected Subjects to Explore the Basis of Accelerated HIV-Disease Progression Associated With Aging.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Emtricitabine; Lopinavir/ritonavir; Stavudine
- Indications HIV infections
- Focus Therapeutic Use
- 07 Nov 2013 Biomarkers information updated
- 28 Sep 2008 Actual initiation date added as 1 Nov 2005 as reported by ClinicalTrials.gov.
- 28 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.